LB Pharmaceuticals Inc Common Stock (LBRX) vs Vor Biopharma Inc. (VOR)

A side-by-side comparison of LB Pharmaceuticals Inc Common Stock and Vor Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LBRX

LB Pharmaceuticals Inc Common Stock

$986M

$34.37HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

VOR

Vor Biopharma Inc.

$999M

$18.44HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

Total return — LBRX vs VOR

growth of $100 · dividends reinvested · last 1y

LBRX +100.1% (+100.1%/yr)VOR -49.0% (-49.0%/yr)LBRX compounded faster over this window

LBRX VOR

LBRX vs VOR: by the numbers

•VOR is the larger company ($999M vs $986M market cap).

Metrics side by side

Valuation

Metric	LBRX	VOR
P/B ratio	2.97	N/A

Profitability

Metric	LBRX	VOR
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-25.78%	N/A
ROIC	-28.14%	-32.24%

Growth (annualized)

Metric	LBRX	VOR
Total return CAGR (5Y)	N/A	-42.54%

Go deeper

Full LBRX analysis Full VOR analysis Interactive comparison tool

Dig into the metrics

LB Pharmaceuticals Inc Common Stock ROE Vor Biopharma ROE LB Pharmaceuticals Inc Common Stock operating margin Vor Biopharma operating margin LB Pharmaceuticals Inc Common Stock revenue growth Vor Biopharma revenue growth LB Pharmaceuticals Inc Common Stock free cash flow Vor Biopharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.